Development and characterization of liquid and solid selfemulsifying drug delivery system of fexofenadine

다국어 초록 (Multilingual Abstract)

Fexofenadine, the active metabolite of terfenadine,a well known and effective H1 receptor antagonist,is administered by the oral route. The objective of present investigation was to develop and characterize a liquid selfemulsifying drug delivery system (SEDDS) and a solid SEDDS by using bioenhancer excipients like Tween 80 and Labrasol which are known for their inhibiting action on CYP450 and P-glycoprotein pump. Solubility of fexofenadine was determined in various vehicles, including oils,surfactants and co-solvents. Various evaluation parameters (emulsification study, particle size, poly-dispersibility index, % drug release, etc.) were carried out to find out optimized liquid SEDDS formulation. Optimized liquid formulations were converted in solid SEDDS by simple and convenient physical adsorption technique. Solid SEDDS was characterized by X-ray diffraction (XRD),differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and Fourier transport infra-red spectroscopy.
The optimized liquid SEDDS formulation contained 29 % Captex 200P/Capmul MCM C8 EP as oil,47 % Labrasol/Tween 80 as a surfactant and 24 % Ethanol as a co-solvent. The optimized liquid and solid SEDDS showed higher drug release than pure API powder. DSC and XRD results of solid SEDDS confirmed that the drug presented in the formulation was in an amorphous state.
The prepared liquid SEDDS and solid SEDDS containing bio-enhancer excipients increased the in vitro dissolution rate of fexofenadine compared to pure drug and has potential to increase bioavailability by blocking Pgp efflux pump and CYP450 hepatic metabolism.

참고문헌 (Reference)

1 Wandel C, "‘‘Inactive’’ excipients such as Cremophor can affect in vivo drug disposition" 73 : 394-396, 2003

2 Wang Z, "Solid selfemulsifying nitrendipine pellets: Preparation and in vitro in vivo evaluation" 383 : 1-6, 2010

3 Neslihan GR, "Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs" 58 : 173-182, 2004

4 Gershanik T, "Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs" 50 : 179-188, 2000

5 Nazzal S, "Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation" 235 : 247-265, 2002

6 Piao HM, "Preparation and evaluation of fexofenadine microemulsions for intranasal delivery" 395 : 309-316, 2010

7 Pandya SJ, "Physical characterization and enhance the solubility of fexofenadine- b-cyclodextrin inclusion complexes" 1 : 260-266, 2011

8 Drescher S, "MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine" 53 : 526-534, 2002

9 Chakraborty S, "Lipid: an emerging platform for oral delivery of drugs with poor bioavailability" 73 : 1-15, 2009

10 Charman WN, "Lipid vehicle and formulation effects on intestinal lymphatic drug transport. Lymphatic transport of drugs" CRC Press 113-179, 1992

11 Cornaire G, "Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo" 278 : 119-131, 2004

12 Pouton CW, "Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies" 60 : 625-637, 2008

13 Jahan ST, "Enhancement of dissolution profile for oral delivery of fexofenadine Hydrochloride by solid dispersion (solvent evaporation) technique" 2 : 112-115, 2011

14 Balakrishnan P, "Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS)" ELSEVIER SCIENCE BV 72 : 539-545, 2009

15 Rege BD, "Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers" 16 : 237-246, 2002

16 Shimizu M, "Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein" 61 : 538-544, 2006

17 Tang B, "Development of solid selfemulsifying drug delivery systems: preparation techniques and dosage forms" 13 : 606-612, 2008

18 Patel HK, "Development and characterization of liquid and solid selfmicroemulsifying drug delivery system of Tacrolimus" 6 : 204-209, 2012

19 Date AA, "Design and evaluation of selfnanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil" 329 : 166-172, 2007